TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
MicroPort NeuroTech Limited ( (HK:2172) ) has provided an announcement.
MicroPort NeuroTech Limited has announced the grant of 500,000 share options to Dr. Will Zhang, the R&D Senior Director of BCI Technologies and Chief Researcher at the Chaos Brain-Computer Research Institute. This move is part of the company’s Share Scheme aimed at incentivizing key personnel to drive business development and success. The options, which have a ten-year validity and a five-year vesting period, are intended to motivate Dr. Zhang by providing a personal stake in the company, aligning with the company’s strategy to enhance performance and efficiency without imposing additional performance targets.
The most recent analyst rating on (HK:2172) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on MicroPort NeuroTech Limited stock, see the HK:2172 Stock Forecast page.
More about MicroPort NeuroTech Limited
MicroPort NeuroTech Limited is a company focused on developing brain-computer interface (BCI) technologies, with a strong emphasis on BCI hardware system development, software algorithm design, and electrode technology innovation. The company operates within the medical device industry, leveraging extensive expertise in electrical engineering and implantable medical devices.
Average Trading Volume: 5,403,370
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.25B
Learn more about 2172 stock on TipRanks’ Stock Analysis page.